“…Conversely, patients with abnormally low antithrombin III levels, heterozygosity for the prothrombin promotor G20210A mutation, or both had a 100% chance of developing PE. Kim et al [4] reported that the absence of thrombophilic polymorphisms, particularly factor V Leiden mutation, antithrombin III deficiency, and prothrombin promoter G20210A mutation, signaled a low incidence of DVT and PE, especially when combined with low clinical prothrombotic risk factors (obesity, prolonged immobilization, venous diseases, hyperlipidemia, etc.). Our study confirmed their findings [6][7][8]17,19,21,23].…”